ATS Medical (ATSI) Announces FDA Okay of the ATS Simulus Adjustable Annuloplasty Band
More News related to ATSI
- ATS Medical to Participate in the 21st Annual Piper Jaffray Health Care Conference
- ATS Medical to Participate in the 2009 Canaccord Adams Cardiovascular Conference
- Piper Jaffray Upgrades ATS Medical (ATSI) to Overweight; Trims 2010 EPS Outlook
- After-Hours Movers 11/02: BDK, DDRX, ATSI, HLF, HTCH, SNCR, CAR Higher; TNS, HIMX, SVR, TXRH Lower
- ATS Medical (ATSI) Posts Q3 Loss of 1c, In-Line with Estimates
More News related to FDA
- After-Hours Movers 12/01: SNTS, ABCW, RAME, GAME Higher; HEB, SWS, RGNC, LTXC Lower
- Trading Radar for 12/2: Aeropostale (ARO), Synopsys (SNPS), Shanda Interactive (SNDA), Jo-Ann Stores (JAS) Report
- Unusual 11 Mid-Day Movers 12/01: BIOF, ZN, GSIT, CAGC, RDN Higher; STAA, LTON, ZOOM, OVTI Lower
- Notable ETF Movers 12/01: FXI, EWJ, GDX, BHH Up; FXY, UUP Lower
- Notable Analyst Rating Changes 12/01: FITB, BPFH, MENT, CLWR, LTD, SPWRA Upgraded; NFLX, NUVA Downgraded
ATS Medical, Inc. (Nasdaq: ATSI) announced FDA clearance of the ATS Simulus Adjustable Annuloplasty Band.
The ATS Simulus Adjustable Annuloplasty Band is the next product in a portfolio of mitral valve repair products developed and commercialized through the Company's partnership with Genesee BioMedical.
Related Categories
FDAStocks Mentioned
+0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
